Tenderwize
Back to tender search

Epinephrine (ATC C01CA24)

AOK - Die Gesundheitskasse in Hessen·Bad Homburg, Germany·Deadline Dec 01, 2026 · 98 days left·Open·Supplies
Sign up to saveOpen documents
Original notice title

Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V (Open-House-Modell)

38/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

38 / 100

Complexity

42 / 100

Risk factors

Structured data says electronic submission is not allowed, while the XML notice text says prior electronic submission b...

The XML notice text states that the Epinephrin procedure is withdrawn/terminated on 28.02.2026, which may affect whethe...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Jan 2027
  • Conclusion of non-exclusive rebate agreements under §130a(8) SGB V for finished medicinal products with various active substances or combinations.
  • Open-house model: accession/contract conclusion possible at any time under identical conditions.
Show full summary

This is an open-house notice for non-exclusive rebate agreements under §130a(8) SGB V for pharmaceutical products (CPV 33600000) in Germany, led by AOK - Die Gesundheitskasse in Hessen. The notice states that accession/contract conclusion is possible at any time on the same conditions, with no individual negotiations. One lot is explicitly identified: Epinephrin (ATC C01CA24), but the lot is also stated to be withdrawn/terminated on 28.02.2026. No contract value is provided. Electronic submission is not allowed; the XML text indicates prior email submission to the buyer contact, which is an inconsistency to note.

Risks

Structured data says electronic submission is not allowed, while the XML notice text says prior electronic submission b...

The XML notice text states that the Epinephrin procedure is withdrawn/terminated on 28.02.2026, which may affect whethe...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Administrative

  • Submission language is German.
  • Electronic submission is not allowed according to structured data.
  • The XML notice states prior electronic submission by email to [email protected], which conflicts with the structured electronicSubmission flag.

Buyer

Location

Bad Homburg, DEU

Website

www.aok.de

Identifier

DE114110216

Activity

Health

Lots (1)

LOT-0003

Epinephrine (ATC C01CA24)

Open-house rebate agreement for the active substance Epinephrin. The lot is explicitly stated in the XML notice text as being withdrawn/terminated on 28.02.2026, despite also showing a start date of 01.02.2025 and an end date of 31.01.2027 in the structured data. Source: structured data and XML notice text.

SuppliesEU fundedElectronic submission

Location

Germany

Duration

Jan 2025 - Jan 2027

Category

Pharmaceutical products

Deadline

Deadline Dec 01, 2026

Procurement Details

Publication date
22 Jan 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
51271-2026

Documents (1)

Procurement document 1

Similar tenders

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3